Vaishali Pharma Complete Financial Statements

In FY2025, Vaishali Pharma (VAISHALI) reported revenue ₹34 Cr, net profit ₹1 Cr and EPS ₹0.09, with a net profit margin of 2.9% and ROE of 1.5%. Full financial statements from FY2015 to FY2025 (11 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see VAISHALI share price.

11 Years of Data
2025 - 2015

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 2.94% 2025 data
EBITDA Margin 5.88% 2025 data
Operating Margin 4.00% 2025 data
Return on Assets 0.91% 2025 data
Return on Equity 1.54% 2025 data

Balance Sheet Ratios

Current Ratio 21.00 2025 data
Debt to Equity 1.69 2025 data
Equity Ratio 59.09% 2025 data
Asset Turnover 0.31 2025 data

VAISHALI Revenue, Net Profit & EBITDA — Year-on-Year Growth

VAISHALI YoY (Jun 2025 vs Sept 2025) — revenue +36.0%, expenses +45.5%.

Revenue Growth
+36.0%
Year-over-Year
Expense Growth
+45.5%
Year-over-Year
Assets Growth
+37.5%
Year-over-Year
Equity Growth
+51.2%
Year-over-Year
Liabilities Growth
+37.5%
Year-over-Year
Operating Cash Flow Growth
-1900.0%
Year-over-Year
Investing Cash Flow Growth
-100.0%
Year-over-Year
Financing Cash Flow Growth
+2000.0%
Year-over-Year

VAISHALI Income Statement — Revenue, EBITDA & Net Profit

Vaishali Pharma revenue ₹34 Cr, EBITDA ₹2 Cr, net profit ₹1 Cr, EPS ₹0.09 (2025) — net profit margin 2.9%. Explore VAISHALI investment value to estimate fundamental worth using multiple valuation models.

Periods ₹ Crores
Particulars Sept 2025 Jun 2025
Revenue 34 25
Expenses 32 22
EBITDA 2 2
Operating Profit Margin % 4.00% 6.00%
Depreciation 0 0
Interest 0 0
Profit Before Tax 2 2
Tax 1 1
Net Profit 1 1
Earnings Per Share (₹) 0.09 0.10

VAISHALI Balance Sheet — Assets, Liabilities & Shareholders' Equity

VAISHALI total assets ₹110 Cr, total equity ₹65 Cr, total liabilities ₹110 Cr (2025) — ROE 1.5%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020 2019 2018 2017
ASSETS
Total Assets 110 80 79 82 86 66 69 64 45
Current Assets 105 75 73 76 81 61 63 59 40
Fixed Assets 2 2 2 1 1 2 1 1 1
Capital Work in Progress 0 1 1 1 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0 0
Other Assets 107 77 76 80 84 64 67 62 43
LIABILITIES
Total Liabilities 110 80 79 82 86 66 69 64 45
Current Liabilities 5 4 6 3 4 4 5 3 4
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 65 43 41 26 22 21 21 21 4
Share Capital 26 11 11 11 11 11 7 7 3
Reserves & Surplus 39 32 30 16 12 11 15 14 1

VAISHALI Cash Flow Statement — Operating, Investing & Financing

Vaishali Pharma operating cash flow ₹-18 Cr, investing ₹0 Cr, financing ₹19 Cr, net cash flow ₹0 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities -18 1 1 1 2 3 4 -10 1 5 -4
Investing Activities 0 1 0 -1 0 0 0 1 1 3 2
Financing Activities 19 -1 -2 0 -2 -3 -4 9 -1 -8 2
Net Cash Flow 0 1 0 1 0 0 0 0 0 0 0